MC1R reduces scarring and rescues stalled healing in a preclinical chronic wound model
Y. Nawilaijaroen, H. R. Rocliffe, S. Austin-Williams, G. Krilis, A. Pellicoro, K. Zhou, Y. Ji, C. Bain, A. M. Kilpatrick, Y. Chen, M. Crichton, Z. Huang, S. J. Forbes, A. Caporali, J. L. Cash
This study shows that MC1R agonist reduces scarring and improves healing in a chronic wound model by enhancing angiogenesis, lymphangiogenesis, and reducing inflammation.
bioRxiv · Nov 30, 2022 · PreprintPathology